NYSE:WST - West Pharmaceutical Services Stock Price, Forecast & News

West Pharmaceutical Services trades on the New York Stock Exchange (NYSE) under the ticker symbol "WST."

West Pharmaceutical Services announced a quarterly dividend on Tuesday, December 17th. Investors of record on Wednesday, January 22nd will be given a dividend of $0.16 per share on Wednesday, February 5th. This represents a $0.64 annualized dividend and a dividend yield of 0.41%. The ex-dividend date is Tuesday, January 21st. This is a positive change from West Pharmaceutical Services's previous quarterly dividend of $0.15. View West Pharmaceutical Services' Dividend History.

West Pharmaceutical Services declared that its Board of Directors has approved a share repurchase plan on Thursday, February 15th 2018, which authorizes the company to buyback 800,000 shares, according to EventVestor. This buyback authorization authorizes the company to repurchase shares of its stock through open market purchases. Shares buyback plans are generally a sign that the company's leadership believes its stock is undervalued.

West Pharmaceutical Services Inc. (NYSE:WST) posted its quarterly earnings data on Thursday, October, 24th. The medical instruments supplier reported $0.79 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.71 by $0.08. The medical instruments supplier earned $456.10 million during the quarter, compared to analysts' expectations of $450.03 million. West Pharmaceutical Services had a return on equity of 16.66% and a net margin of 12.82%. The business's quarterly revenue was up 5.6% compared to the same quarter last year. During the same period last year, the company earned $0.76 earnings per share. View West Pharmaceutical Services' Earnings History.

West Pharmaceutical Services is scheduled to release their next quarterly earnings announcement on Thursday, February 13th 2020. View Earnings Estimates for West Pharmaceutical Services.

3 brokerages have issued 12 month price objectives for West Pharmaceutical Services' stock. Their forecasts range from $112.16 to $135.00. On average, they anticipate West Pharmaceutical Services' stock price to reach $123.05 in the next year. This suggests that the stock has a possible downside of 21.0%. View Analyst Price Targets for West Pharmaceutical Services.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for West Pharmaceutical Services in the last year. There are currently 1 sell rating, 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for West Pharmaceutical Services.

Press coverage about WST stock has been trending extremely negative on Saturday, according to InfoTrie Sentiment. The research firm scores the sentiment of news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. West Pharmaceutical Services earned a coverage optimism score of -4.5 on InfoTrie's scale. They also assigned press coverage about the medical instruments supplier a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the near future. View News Stories for West Pharmaceutical Services.

West Pharmaceutical Services saw a increase in short interest in December. As of December 31st, there was short interest totalling 1,340,000 shares, an increase of 25.2% from the December 15th total of 1,070,000 shares. Based on an average daily trading volume, of 419,200 shares, the short-interest ratio is currently 3.2 days. Currently, 1.8% of the company's stock are short sold. View West Pharmaceutical Services' Current Options Chain.

Some companies that are related to West Pharmaceutical Services include Align Technology (ALGN), Cooper Companies (COO), DENTSPLY SIRONA (XRAY), Haemonetics (HAE), ICU Medical (ICUI), Neogen (NEOG), Quidel (QDEL), Merit Medical Systems (MMSI), STAAR Surgical (STAA), Atrion (ATRI), Antares Pharma (ATRS), Anika Therapeutics (ANIK), Cerus (CERS), OraSure Technologies (OSUR) and Meridian Bioscience (VIVO).

Based on aggregate information from My MarketBeat watchlists, some companies that other West Pharmaceutical Services investors own include Johnson & Johnson (JNJ), Mcdonald's (MCD), PepsiCo (PEP), AbbVie (ABBV), Lowe's Companies (LOW), Medtronic (MDT), NVIDIA (NVDA), AFLAC (AFL), PPG Industries (PPG) and Sherwin-Williams (SHW).

West Pharmaceutical Services' stock is owned by many different of institutional and retail investors. Top institutional shareholders include Riverbridge Partners LLC (0.80%), AMI Asset Management Corp (0.30%), New York State Teachers Retirement System (0.13%), Nisa Investment Advisors LLC (0.10%), Zurcher Kantonalbank Zurich Cantonalbank (0.08%) and Conestoga Capital Advisors LLC (0.05%). Company insiders that own West Pharmaceutical Services stock include Daniel Malone, Karen Flynn, Patrick J Zenner and William J Federici. View Institutional Ownership Trends for West Pharmaceutical Services.

WST stock was sold by a variety of institutional investors in the last quarter, including Nisa Investment Advisors LLC, AMI Asset Management Corp, Riverbridge Partners LLC, NEXT Financial Group Inc, New York State Teachers Retirement System, First Hawaiian Bank, Eqis Capital Management Inc. and Janney Montgomery Scott LLC. View Insider Buying and Selling for West Pharmaceutical Services.

WST stock was acquired by a variety of institutional investors in the last quarter, including Zurcher Kantonalbank Zurich Cantonalbank, Mckinley Capital Management LLC Delaware, DNB Asset Management AS, IFM Investors Pty Ltd, Sumitomo Mitsui DS Asset Management Company Ltd, Strs Ohio, State of Alaska Department of Revenue and Wedbush Securities Inc.. View Insider Buying and Selling for West Pharmaceutical Services.

Shares of WST can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of WST stock can currently be purchased for approximately $155.75.

West Pharmaceutical Services has a market capitalization of $11.52 billion and generates $1.72 billion in revenue each year. The medical instruments supplier earns $206.90 million in net income (profit) each year or $2.81 on an earnings per share basis. West Pharmaceutical Services employs 7,700 workers across the globe.View Additional Information About West Pharmaceutical Services.

The official website for West Pharmaceutical Services is http://www.westpharma.com/.

West Pharmaceutical Services' mailing address is 530 HERMAN O. WEST DRIVE, EXTON PA, 19341. The medical instruments supplier can be reached via phone at 610-594-2900 or via email at [email protected]